474 assets in Plasma Cell Myeloma

Therapeutic assets addressing Plasma Cell Myeloma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Apixaban Plasma Cell Myeloma	Centre Hospitalier Universitaire de Saint Etienne	P4	B (61)
Aspirin Plasma Cell Myeloma	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P3	B (61)
Conjugated Pneumococcal Vaccine Plasma Cell Myeloma	Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology	P4	B (61)
Endoxan Plasma Cell Myeloma	Celyad Oncology SA	P3	B (61)
Fludeoxyglucose Plasma Cell Myeloma	National Cancer Institute (NCI)	P3	B (61)
Human Immunoglobulins Plasma Cell Myeloma	Monash University	P2/3	B (61)
Ibrutinib Plasma Cell Myeloma	Anne Louise Tølbøll Sørensen	P4	B (61)
Melphalan Hydrochloride For Plasma Cell Myeloma	Peking University People's Hospital	P4	B (61)
Mesna Plasma Cell Myeloma	Indapta Therapeutics, INC.	P4	B (61)
Mitoxantrone Plasma Cell Myeloma	Affiliated Hospital of Nantong University	P4	B (61)
Plerixafor Plasma Cell Myeloma	Thomas Jefferson University	P3	B (61)
Rituximab Plasma Cell Myeloma	Indapta Therapeutics, INC.	P2	B (61)
Sulfamethoxazole Plasma Cell Myeloma	Monash University	P3	B (61)
Tocilizumab Plasma Cell Myeloma	SCRI Development Innovations, LLC	P4	B (61)
Trimethoprim Plasma Cell Myeloma	Monash University	P3	B (61)
Venetoclax Plasma Cell Myeloma	Oncotherapeutics	P3	B (61)
Epirubicin Plasma Cell Myeloma	Andrew Hantel, MD	P3	B (60)
Leflunomide Plasma Cell Myeloma	City of Hope Medical Center	P2	B (60)
Lomustine Plasma Cell Myeloma	Actuate Therapeutics Inc.	P3	B (60)
Ondansetron Plasma Cell Myeloma	Fate Therapeutics	P3	B (60)
Pelareorep Plasma Cell Myeloma	University of Southern California	P1/2	B (60)
Phosphonic Acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-2,5-Dihydro-5-Oxo-1H-1,2,4-Triazol-1-Yl]- Plasma Cell Myeloma	The Affiliated People's Hospital of Ningbo University	P3	B (60)
Selinexor Plasma Cell Myeloma	Natalie Callander	P3	B (60)
Nivolumab Plasma Cell Myeloma	Wake Forest University Health Sciences	P3	B (59)
sg301 Plasma Cell Myeloma	Hangzhou Sumgen Biotech Co., Ltd.	P3	B (59)
Sirolimus Plasma Cell Myeloma	National Cancer Institute (NCI)	P3	B (59)
Arlocabtagene Autoleucel Plasma Cell Myeloma	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	P3	B (58)
azd0120 Plasma Cell Myeloma	AstraZeneca	P3	B (58)
Bcma Car-T Cells Plasma Cell Myeloma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	B (58)
Belantamab Mafodotin Plasma Cell Myeloma	GlaxoSmithKline	P3	B (58)
Bendamustine Plasma Cell Myeloma	Uppsala University	P3	B (58)
Dasatinib Plasma Cell Myeloma	Centro de Atencion e Investigacion Medica	P4	B (58)
gr1803 Plasma Cell Myeloma	Genrix (Shanghai) Biopharmaceutical Co., Ltd.	P3	B (58)
hbi0101 cart Plasma Cell Myeloma	Hadassah Medical Organization	P2	B (58)
Irinotecan Plasma Cell Myeloma	Leaf Vertical Inc.	P2	B (58)
Jnj-79635322 Plasma Cell Myeloma	Janssen Research & Development, LLC	P3	B (58)
Ketorolac Plasma Cell Myeloma	Sanofi	P3	B (58)
Loratadine Plasma Cell Myeloma	Emory University	P4	B (58)
Panobinostat Plasma Cell Myeloma	Abdullah Khan	P3	B (58)
Pegfilgrastim Plasma Cell Myeloma	The Affiliated People's Hospital of Ningbo University	P3	B (58)
Pembrolizumab Plasma Cell Myeloma	Andrew Hantel, MD	P3	B (58)
ql2109 Plasma Cell Myeloma	Qilu Pharmaceutical Co., Ltd.	P3	B (58)
Ruxolitinib Plasma Cell Myeloma	Oncotherapeutics	P2	B (58)
Sapanisertib Plasma Cell Myeloma	National Cancer Institute (NCI)	P2	B (58)
Xembify Plasma Cell Myeloma	Grifols Therapeutics LLC	P3	B (58)
Zanubrutinib Plasma Cell Myeloma	Anne Louise Tølbøll Sørensen	P4	B (58)
Trametinib Plasma Cell Myeloma	Cancer Research UK	P2/3	B (57)
Recombinant Human Hyaluronidase Plasma Cell Myeloma	National Cancer Institute (NCI)	P2	B (56)
Temsirolimus Plasma Cell Myeloma	Canadian Cancer Trials Group	P2	B (56)
Vorinostat Plasma Cell Myeloma	OHSU Knight Cancer Institute	P3	B (56)

Showing 51 to 100 of 474 assets

PreviousPage 2 of 10Next